"Rokotetutkimuskeskus on Tampereen yliopiston lääketieteen ja terveysteknologian tiedekunnan alaisuudessa toimiva erikoisyksikkö. Toteutamme tieteellisesti ja eettisesti korkeatasoisia, kliinisiä rokotetutkimuksia yhdessä rokotevalmistajien kanssa, sekä omia akateemisia tutkimushankkeita. Tavoitteemme on saada käyttöön uusia, entistä turvallisempia ja tehokkaampia rokotteita lapsille, nuorille ja aikuisille. Rokotetutkimuskeskusta johtaa professori Mika Rämet."

During the past decade, Jarvenpaa Vaccine Research Clinic conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 12 clinical trials were completed, i.e. on average, 109.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jarvenpaa Vaccine Research Clinic" #1 sponsor was "Pfizer" with 10 trials, followed by "Janssen Vaccines & Prevention B.V." with 3 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Novartis" with 1 trials sponsored and "Novartis Vaccines" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jarvenpaa Vaccine Research Clinic" #1 collaborator was "Novartis Vaccines" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Jarvenpaa Vaccine Research Clinic" are "Meningococcal Vaccine" (5 trials), "Pneumococcal Infections" (2 trials), "Respiratory Syncytial Viruses" (2 trials), "Hepatitis B Vaccines" (1 trials) and "Infections, Meningococcal" (1 trials). Many other conditions were trialed in "Jarvenpaa Vaccine Research Clinic" in a lesser frequency.

Most popular intervention types in "Jarvenpaa Vaccine Research Clinic" are "Biological" (17 trials), "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Saline" (3 trials), "rLP2086" (3 trials), "Nimenrix" (2 trials) and "13-valent pneumococcal conjugate vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jarvenpaa Vaccine Research Clinic" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Jarvenpaa Vaccine Research Clinic". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Jarvenpaa Vaccine Research Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jarvenpaa Vaccine Research Clinic, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".